Physician profile
Mita Gupta
NPI 1912977646
$1,818.79
in general payments reported to CMS, 2019-2025
18 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $187 · 2021: $180 · 2022: $132 · 2023: $349 · 2024: $484 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848 · Entertainment: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.20 |
| Entertainment | $165.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $287.75 | 2021-2025 | Precision 1, Total30, Dailies Total1 |
| Optos, INC. | $209.01 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $160.43 | 2020-2024 | Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $160.05 | 2019-2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $127.76 | 2020-2023 | Acuvue |
| Shire North American Group INC | $121.66 | 2019 | |
| Maculogix, INC. | $117.92 | 2020 | |
| Harrow Eye, LLC | $113.51 | 2025 | Vevye |
| Sight Sciences, INC. | $111.75 | 2024 | Omni Surgical System |
| Biotissue Holdings INC. | $92.32 | 2024 | |
| Rxsight INC | $78.39 | 2022 | |
| Allergan, INC. | $72.72 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $43.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.66 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $22.07 | 2024 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.85 | 2024 | |
| Bausch & Lomb Americas INC. | $18.98 | 2025 | Vyzulta |
| Kala Pharmaceuticals, INC. | $18.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mita Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.